Entrada Therapeutics, Inc.TRDANASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Percentile
P0
Near historical low
vs 2Y Ago
-0.9x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$-128.51M-209.2%
2024$-41.56M-129.7%
2023$139.80M+249.1%
2022$-93.79M-84.4%
2021$-50.86M-98.9%
2020$-25.57M-136.7%
2019$-10.80M-